Pharmacokinetics of clinafloxacin after single and multiple doses (Q33982904)

30 July 2017

title

Pharmacokinetics of clinafloxacin after single and multiple doses (English)

1 reference

30 July 2017

1 reference

Randinitis EJ

1

1 reference

30 July 2017

Brodfuehrer JI

series ordinal

2

1 reference

30 July 2017

Eiseman I

series ordinal

3

1 reference

30 July 2017

Vassos AB

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 July 2017

volume

45

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

2529-2535

1 reference

Pharmacokinetics of clinafloxacin enantiomers in humans.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90688

Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90688

In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90688

Pharmacokinetics and Inflammatory Fluid Penetration of Clinafloxacin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90688

The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90688

The quinolones. An overview of their pharmacology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90688

The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90688

Bacterial eradication by clinafloxacin, CI-990, and ciprofloxacin employing MBC test, in-vitro time-kill and in-vivo time-kill studies

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90688

Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11502525

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11502525

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.45.9.2529-2535.2001

1 reference

30 July 2017

1 reference

30 July 2017

1 reference